The 2024 British Society for Rheumatology guideline for management of systemic sclerosis-executive summary.

Autor:	Denton CP; Division of Medicine, University College London, London, UK., De Lorenzis E; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Roblin E; Centre for Rheumatology, Royal Free London NHS Foundation Trust, London, UK., Goldman N; Division of Medicine, University College London, London, UK., Alcacer-Pitarch B; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Blamont E; Scleroderma and Raynaud's UK (SRUK), London, UK., Buch MH; Department of Rheumatology, University of Manchester, Manchester, UK., Carulli M; Department of Rheumatology, Hammersmith Hospitals NHS Foundation Trust, London, UK., Cotton C; Department of Rheumatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Del Galdo F; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Derrett-Smith E; Department of Rheumatology, University of Birmingham, Birmingham, UK., Douglas K; Department of Rheumatology, The Dudley Group NHS Foundation Trust, Dudley, UK., Farrington S; Scleroderma and Raynaud's UK (SRUK), London, UK., Fligelstone K; Centre for Rheumatology, Royal Free London NHS Foundation Trust, London, UK., Gompels L; Department of Rheumatology, Somerset NHS Foundation Trust, Taunton, UK., Griffiths B; Department of Rheumatology, Freeman Hospital, Newcastle, UK., Herrick A; Department of Rheumatology, University of Manchester, Manchester, UK., Hughes M; Department of Rheumatology, University of Manchester, Manchester, UK., Pain C; Department of Rheumatology, Alder Hey Children's Hospital, Liverpool, UK., Pantano G; Lived Experience, London, UK., Pauling JD; Department of Rheumatology, North Bristol NHS Foundation Trust, Bristol, UK., Prabu A; Department of Rheumatology, University of Birmingham, Birmingham, UK., O'Donoghue N; Department of Dermatology, Salford Royal, Northern Care Alliance, Salford, UK., Renzoni EA; Interstitial Lung Disease Unit, Royal Brompton NHS Foundation Trust, London, UK., Royle J; Department of Rheumatology, University Hospitals NHS Foundation Trust, Leicester, UK., Samaranayaka M; Department of Rheumatology, Salford Royal, Northern Care Alliance, Salford, UK., Spierings J; Department of Rheumatology, University of Utrecht, Utrecht, Netherlands., Tynan A; Centre for Rheumatology, Royal Free London NHS Foundation Trust, London, UK., Warburton L; Primary Care Sciences, Keele University, Keele, UK., Ong VH; Division of Medicine, University College London, London, UK.
Jazyk:	angličtina
Zdroj:	Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Nov 01; Vol. 63 (11), pp. 2948-2955.
DOI:	10.1093/rheumatology/keae390
Abstrakt:	This guideline was developed according to the British Society for Rheumatology Guidelines Protocol by a Guideline Development Group comprising healthcare professionals with expertise in SSc and people with lived experience, as well as patient organization representatives. It is an update of the previous 2015 SSc guideline. The recommendations were developed and agreed by the group and are underpinned by published evidence, assessed by systematic literature review and reinforced by collective expert opinion of the group. It considers all aspects of SSc including general management, treatment of organ-based complications, including cardiopulmonary, renal and gastrointestinal tract manifestations, as well as broader impact of disease. Whilst it is focused on adults with SSc we expect that the guideline will be relevant to people of all ages and expert input and review by paediatric rheumatologists and other relevant specialists considered where the guideline was, or may not be, applicable to young people with SSc and juvenile-onset disease. In addition to providing guidance on disease assessment and management the full guideline also considers service organization within the National Health Service and future approaches to audit of the guideline. The lay summary that accompanies this abstract can be found in Supplemental information 1. (© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu